参考文献/References:
[1]王慧,郑立,文逸凡,等.动物FABP基因家族研究进展及育种应用探讨[J].基因组学与应用生物学,2018,37(12):5275-5280.[2]林茂上.卵形鲳鯵仔、稚鱼脂肪酸结合蛋白克隆与表达的研究[D].大连海洋大学,2018.[3]盘道兴,王振,杨茂林,等.江口萝卜猪FABPs主要家族基因SNPs筛选及生物信息学分析[J].基因组学与应用生物学,2015,34(1):47-52.[4]黄荣东.FABP1基因启动子多态性与血脂的关联及功能研究[D].福建医科大学,2016.[5]吴云丽.乙型肝炎病毒X蛋白(HBx)对人FABP1和NQO1基因调控及机制研究[D].福建医科大学,2012.[6]Schroeder F,McIntosh AL,Martin GG,et al.Fatty Acid Binding Protein-1(FABP1)and the Human FABP1 T94A Variant:Roles in the Endocannabinoid System and Dyslipidemias[J].Lipids,2016,51(6):655-676.[7]Galassi VV,Villarreal MA,Montich GG.Relevance of the protein macrodipole in the membrane-binding process.Interactions of fatty-acid binding proteins with cationic lipid membranes[J].PLoS One,2018,13(3):e0194154.[8]姜华,高建鹏,胡阳,等.肝性脂肪酸结合蛋白基因单核苷酸多态性表达与NAFLD的相关性[J].实用医学杂志,2020(1):84-88.[9]Martin GG,Seeger DR,McIntosh AL,et al.Sterol Carrier Protein-2/Sterol Carrier Protein-x/Fatty Acid Binding Protein-1 Ablation Impacts Response of Brain Endocannabinoid to High-Fat Diet[J].Lipids,2019,54(10):583-601.[10]Elmes MW,Prentis LE,McGoldrick LL,et al.FABP1 controls hepatic transport and biotransformation of 9-THC[J].Scientific Reports,2019,9(1):7588.[11]Li WW,Huang D,Shen PC,et al.Effects of Gubentongluo Formula on Oxidative Stress Reflected by Expressions of PPARα and FABP1 in Mice with IgA Nephropathy[J].Journal of Sichuan University(Medical Science Edition),2017,48(2):210-215.[12]Church RJ,Kullak-Ublick GA,Aubrecht J,et al.Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury:An international collaborative effort[J].Hepatology,2019,69(2):760-773.[13]Meunier L,Larrey D.Drug-Induced Liver Injury:Biomarkers,Requirements,Candidates,and Validation[J].Front Pharmacol,2019(10):1482. [14]Mikus M,Drobin K,Gry M,et al.Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury[J].Liver Int,2017,37(1):132-140.[15]Belcher JM,Garcia-Tsao G,Sanyal AJ,et al.Urinary biomarkers and progression of AKI in patients with cirrhosis[J].Clin J Am Soc Nephrol,2014,9(11):1857-1867.[16]Mukai T,Egawa M,Takeuchi T,et al.Silencing of FABP1 ameliorates hepatic steatosis,inflammation,and oxidative stress in mice with nonalcoholic fatty liver disease[J].FEBS Open Bio,2017,7(7):1009-1016.[17]Pi H,Liu M,Xi Y,et al.Long-term exercise prevents hepatic steatosis:a novel role of FABP1 in regulation of autophagy-lysosomal machinery[J].FASEB J,2019,33(11):11870-11883.[18]张英.CBR1和FABP1在联苯双酯抗大鼠肝纤维化中的作用[D].河北医科大学,2015.[19]钟承千.脂肪型脂肪酸结合蛋白在肝细胞癌发生发展中的功能和机制研究[D].福建医科大学,2017.[20]Ku CY,Liu YH,Lin HY,et al.Liver fatty acid-binding protein(FABP1)promotes cellular angiogenesis and migration in hepatocellular carcinoma[J].Oncotarget,2016,7(14):18229-18246.[21]Sharaf RN,Butte AJ,Montgomery KD,et al.Computational prediction and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes[J].BMC Gastroenterology,2011(11):5.[22]Dharmarajan S,Newberry EP,Montenegro G,et al.Liver fatty acid-binding protein(L-Fabp)modifies intestinal fatty acid composition and adenoma formation in ApcMin/+ mice[J].Cancer Prev Res(Phila),2013,6(10):1026-1037.[23]Jiang Z,Shen H,Tang B,et al.Quantitative proteomic analysis reveals that proteins required for fatty acid metabolism may serve as diagnostic markers for gastric cancer[J].Clin Chim Acta,2017(464):148-154.[24]Wood SM,Gill AJ,Brodsky AS,et al.Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway[J].Mod Pathol,2017,30(1):123-133.[25]Parr SK,Clark AJ,Bian A,et al.Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury[J].Kidney Int,2015,87(3):640-648.[26]Lewandowska L,Malyszko J,Joanna Matuszkiewicz-Rowińska J.Urinary and Serum Biomarkers for Prediction of Acute Kidney Injury in Patients Undergoing Liver Transplantation[J].Ann Transplant,2019(24):291-297.[27]祁洁,王钊华,董自杰,等.尿KIM-1、L-FABP、NGAL检测对早期AKI患儿的诊断价值探讨[J].临床和实验医学杂志,2019,18(22):2438-2441. [28]Katayama M,Miyazaki T,Ohata K,et al.Temporal changes in urinary excretion of liver-type fatty acid binding protein(L-FABP)in acute kidney injury model of domestic cats:a preliminary study[J].J Vet Med Sci,2019,81(12):1868-1872.[29]Watanabe S,Ichikawa D,Sugaya T,et al.Urinary Level of Liver-Type Fatty Acid Binding Protein Reflects the Degree of Tubulointerstitial Damage in Polycystic Kidney Disease[J].Kidney Blood Press Res,2018,43(6):1716-1729.[30]Plesiński K,Adamczyk P,Swietochowska E,et al.Evaluation of liver-type fatty acid binding protein(L-FABP)and interleukin 6 in children with renal cysts[J].Adv Clin Exp Med,2019,28(12):1675-1682.[31]Panduru NM,Forsblom C,Saraheimo M,et al.Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes[J].Diabetologia,2017,60(9):1782-1790.[32]Suh JS,Kim SH,Cho KS,et al.Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes[J].Pediatr Nephrol,2016,31(4):623-631.[33]Yang X,Zhang B,Lu X,et al.Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease:post-hoc findings from a multi-center,randomized,double-blind,placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease[J].BMC Complementary and Alternative Medicine,2016(16):246.
相似文献/References:
[1]李新刚.抗结核药物治疗所致肝损伤患者的危险因素及其治疗转归观察[J].医学信息,2019,32(03):155.[doi:10.3969/j.issn.1006-1959.2019.03.051]
LI Xin-gang.Risk Factors and Treatment Outcomes of Patients with Liver Injury Caused by Anti-tuberculosis Drugs[J].Medical Information,2019,32(10):155.[doi:10.3969/j.issn.1006-1959.2019.03.051]
[2]付晓春,沈小莉,李红群,等.雷公藤多苷促进斑马鱼肝脏损伤和氧化应激的实验研究[J].医学信息,2019,32(05):79.[doi:10.3969/j.issn.1006-1959.2019.05.024]
FU Xiao-chun,SHEN Xiao-li,LI Hong-qun,et al.Experimental Study on the Effects of Tripterygium Glycosides on Liver Damage and Oxidative Stress in Zebrafish[J].Medical Information,2019,32(10):79.[doi:10.3969/j.issn.1006-1959.2019.05.024]
[3]蒋红梅.丙基硫氧嘧啶与甲巯咪唑治疗妊娠合并甲状腺功能亢进的疗效比较[J].医学信息,2019,32(05):154.[doi:10.3969/j.issn.1006-1959.2019.05.049]
JIANG Hong-mei.Comparison of Propyl Thiouracil and Methimazole in the Treatment of Pregnancy with Hyperthyroidism[J].Medical Information,2019,32(10):154.[doi:10.3969/j.issn.1006-1959.2019.05.049]
[4]王 静,郭宏敏.肝型脂肪酸结合蛋白在糖尿病中的研究[J].医学信息,2019,32(18):18.[doi:10.3969/j.issn.1006-1959.2019.18.007]
WANG Jing,GUO Hong-min.Study on Hepatic Fatty Acid Binding Protein in Diabetes[J].Medical Information,2019,32(10):18.[doi:10.3969/j.issn.1006-1959.2019.18.007]
[5]吕雅云,龚先琼.女贞子提取物治疗肝病的研究[J].医学信息,2020,33(03):31.[doi:10.3969/j.issn.1006-1959.2020.03.010]
LYU Ya-yun,GONG Xian-qiong.Study on Ligustrum Lucidum Extract in Treating Liver Disease[J].Medical Information,2020,33(10):31.[doi:10.3969/j.issn.1006-1959.2020.03.010]
[6]郭 冶,卢凤美,刘东璞.肝纤维化发病机制及大黄酸对肝纤维化的作用[J].医学信息,2020,33(12):27.[doi:10.3969/j.issn.1006-1959.2020.12.010]
GUO Ye,LU Feng-mei,LIU Dong-pu.The Pathogenesis of Hepatic Fibrosis and the Effect of Rhein on Hepatic Fibrosis[J].Medical Information,2020,33(10):27.[doi:10.3969/j.issn.1006-1959.2020.12.010]
[7]陈 玲,龚先琼.中药单体减轻对乙酰氨基酚诱导肝损伤的研究[J].医学信息,2021,34(15):1.[doi:10.3969/j.issn.1006-1959.2021.15.001]
CHEN Ling,GONG Xian-qiong.Study on the Effect of Chinese Herbal Medicine on Reducing the Liver Injury Induced by Acetaminophen[J].Medical Information,2021,34(10):1.[doi:10.3969/j.issn.1006-1959.2021.15.001]
[8]张满英,吴春城,毛乾国,等.以肝功能损害为主要表现的EV71感染1例报道[J].医学信息,2021,34(19):187.[doi:10.3969/j.issn.1006-1959.2021.19.052]